Numelvi Tablets 7.2 mg for Itch relief for Medium Dogs

NUMELVI is a daily tablet that serves as a primary treatment option and stands out as the only second-generation Janus kinase (JAK) inhibitor approved for alleviating itching linked to allergic dermatitis, such as atopic dermatitis, in dogs. Numelvi represents the next evolution in itch relief, providing an innovative solution for managing canine allergic dermatitis with a focus on selectivity, safety, and ease of use. Active Ingredients Numelvi is formulated with Atinvicitinib. Indications This medication is intended for alleviating pruritus associated with allergic dermatitis, including atopic dermatitis, in dogs. It also addresses inflammation and other clinical signs of atopic dermatitis in dogs.
Expires on 31 Mar 2029